How delayed and non-adherent treatment contribute to onward transmission of malaria: a modelling study

INTRODUCTION: Artemether-lumefantrine (AL) is the most widely-recommended treatment for uncomplicated Plasmodium falciparum malaria. Its efficacy has been extensively assessed in clinical trials. In routine healthcare settings, however, its effectiveness can be diminished by delayed access to treatm...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:BMJ Glob Health
Autori principali: Challenger, Joseph D, Gonçalves, Bronner P, Bradley, John, Bruxvoort, Katia, Tiono, Alfred B, Drakeley, Chris, Bousema, Teun, Ghani, Azra C, Okell, Lucy C
Natura: Artigo
Lingua:Inglês
Pubblicazione: BMJ Publishing Group 2019
Soggetti:
Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6936434/
https://ncbi.nlm.nih.gov/pubmed/31908862
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjgh-2019-001856
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi